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Abstract. Violacein is a pigment found in Chromobacterium 
violaceum, it has a number of properties, such as; anti-bacterial, 
anti-viral, anti-protozoa, anti-tumoral. Violacein is produced by a 
series of genes named vioA, vioB, vioC, vioD and vioE. A 
violacein sequence is 8 kilo-bases (kb) in size. The goal of this 
study was to isolate the smallest possible fragment of 
'Deoxyribonucleic acid' (DNA) that would produce violacein from 
pJP101 and making a connection to DNA biological logic gates. 
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1. Introduction 
The hypothesis posed is as follows, ‘the extraction of the violacein sequence from 
pJP101 for expression and analysis in pHSG398 determine the smallest 
'Deoxyribonucleic acid' (DNA) fragment responsible for purple pigmentation’. This 
paper aims to develop an experimentation process and applies the process to 
validate the hypothesis within a hybrid biology and rheology context.  
In molecular biology it is important to be able to identify and isolate DNA 
sequences of interest for expression and analysis.  This can be achieved through 
the amplification and isolation of genetic material, with techniques such as 
'Polymerase chain reaction' (PCR) and restriction digests [1].  
The techniques PCR and restriction digest can be used to identify gene 
products, such as resistance genes in bacteria [2], Furthermore, these techniques 
are important in the development of antibiotics, as pathogens continue to develop 
resistance to many common antibiotics [3], due to this it is important to look for 
different types of antibiotics. One such example of this is violacein. 
Violacein is a purple pigment produced by Chromobacterium violaceum which 
is a Gram-negative bacterium found in soil and water in tropical and subtropical 
regions [4].  C. violaceum is rarely infectious in mammals and comes in 2 strains; 
pigmented and un-pigmented. Violacein has been extensively researched, which 
has shown it has many properties and potential uses, such as;   
• Protecting C. violaceum by triggering cell death and lysis in 
bacterivorous flagellate after ingestion [5] 
• Inhibit the growth of the plasmodium parasites, such as the ones which 
cause malaria [6] 
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• Exhibits some antiviral properties as demonstrated against HSV-1, 
may exhibit greater anti-viral activity by incasing violacein in a 
liposome [7] 
• Demonstrated the ability to affect HL60 leukemia cells, it achieves this 
by activating tumor necrosis factor receptor signaling, causing 
apoptosis [8] 
 
 
2. Background and Contextualization 
One way of finding new antibiotics is by studying bacterium to see if they have any 
antibiotic properties [9]. By isolating a bacterium’s genetic material it is possible to 
generate a genomic library, where the genetic material responsible for the 
antibiotics production can be identified and cloned for expression [10].  The size of 
a piece of genetic material is generally shown as the number of DNA base pairs it 
consists of, this measurement is usually given either as a single unit (‘base pairs’ 
[bp])  or in units of a thousand (kilo-bases [kb]).  
 
2.1.  Molecular biology context 
To obtain genetic material for identification, a restriction digest maybe 
performed. Restriction digests utilizes a restriction enzymes ability to cleave DNA 
at defined sites usually 4 to 8 bp in length (restriction sites) [11], multiple ‘restriction 
sites’ may be scattered throughout an organisms genome. Multiple types of 
restriction enzymes can be used to fragment an organisms genome.  This 
fragmented genetic material can then be inserted into a vector plasmid for 
sequencing and/or to identify an organism/gene of interest [12].  Once a gene has 
been identified, it may be amplified via PCR.  
There are three basic steps involved in PCR [13]: 
• Initially DNA is denatured from its usual double stranded form into a 
single stranded form, 
• Then specific primers (short sequences of single stranded DNA) 
anneal to the single stranded DNA, and 
• Once annealed a heat dependent polymerase is used to replicate DNA 
from where the primers have annealed. 
 
 
 
Figure 1. PCR tubes with reaction mixture placed in thermal cycler that is used in targeted DNA 
sequence amplification [9]. 
 
 The PCR cycles are repeated multiple times to generate a large number of 
copies of the sequence of interest, which then can be either inserted into a vector 
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for uptake and expression or sequenced to identify its genetic sequence. Primers 
can be designed to include specific restriction enzyme sites, which can be used to 
ensure the genetic material is inserted in the right direction [14]. 
2.2. Violacein context 
The genes responsible for the production of violacein form a large metabolic 
pathway, which has 5 specific regions, these regions are; vioA (1,257 bp), vioB 
(2,997 bp), vioC (1,290 bp), vioD (1,122 bp) [15] and vioE, giving a total sequence 
length of ~8 kb [16]. 
 
Violacein is produced by combining two L-tryptophan (Figure 2), the process 
by which it is synthesized is as follows [17]: 
• Initially vioA removes an amine group from the terminal end of one L-
tryptophan and replacing it with a ketone,  
• On another L-tryptophan, vioD adds an alcohol group to the hexane 
ring, and then vioE causes a 1-2 shift with the carboxylic acid and 
amine group, 
• vioB combines the two L-tryptophan to create a violacein intermediate, 
an in the process removes carboxylic groups from each terminal end, 
and 
• vioC then adds an alcohol group to the N-ring attached to the hexane 
ring without any functional groups, this alcohol is then transformed into 
a ketone group, thus forming violacein. 
 
 
Figure 2. Biosynthetic pathway for the production of violacein in C.violaceum, showing products, 
reagents and gene products used, also shows changes in structure of violacein as the reaction [18].  
2.3. Logic gate context 
A nexus appears to exist between the ‘waking up’ of a sleeping virus (genes 
are turned on and off) [19] and DNA ‘switches’ that act as biological logic gates.  
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Violacein may be the switching mechanism as it appears to activate tumor necrosis 
factor receptor signaling [16] and an alignment to a traditional approach of dealing 
with logic gates within a 'Central processing Unit' (CPU) hierarchy (logic device).  
Once mapped (Figure 3), the violacein gene domains could have causality with 
NOT [inputs opposite to output] logic gate blocks [20] and be extracted as the 
smallest possible bp fragment in a bio machine. 
 
Figure 3. logic gates within a 'Central processing Unit' (CPU) hierarchy (logic device) [21]. 
3. Experimentation 
The aim of this experiment was to try and extract the smallest possible fragment 
from pJP101 which contained the violacein genes. 
3.1. Fragmented pJP101 context 
Plasmid JP101 was the created by Pemeberton and colleauges (1991) [22], it 
was the smallest plasmid created expressing violacein in the study.  Plasmid 
JP101 (Figure 4) was assembled by ligating chromosomal DNA into the BamHI site 
of the Trasnposon n5, this was followed up by infection of E.coli of the clones of the 
experiment (JMP2540) carried the cosmid pJP100, which contained a 30 kb insert.  
A smaller insert was obtained by partially digesting pJP100 with Sau3AI and 
ligating it into pBR332 which had been digested with BamHI.  This clone was 
named pJP101, the DNA fragment containing the violacein genes in pJP101 was 
14.5 kb. 
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Figure 4. Diagram of pJP101 showing amphilcilin resistance (Ap
r
) and violacein genes. The diagram 
also shows EcoRI sites. Plasmid JP101 also has multiple Sau3AI sites scattered throughout its genome 
(not shown) [22]. 
3.2. Vector pHSG398 context 
Plasmid HSG398 was used as the vector for the violacein genes (Figure 5).  
Plasmid HSG398 was selected as it has a different antibiotic resistance than that of 
pJP101, to allow for antibiotic screening.  Plasmid HSG398 was also selected for 
this experiment as it only has one BamHI restriction site in its multi cloning region 
[23]. 
 
Figure 5. Plasmid map of pHSG398, showing; plasmid size, origin of replication, antibiotic resistance 
(Cm
r
), and LacZ region. Shown inside the LacZ region is pHSG398 multiple cloning sites, shown in 
greater detail above plasmid map [23]. 
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3.3. Techniques context 
The techniques used in this experiment are usually used to make a genetic 
library.  This can be done by performing enzyme dilution digests on DNA of interest.  
Serial digests work by using varying amounts of enzyme to fragment a plasmid, 
these fragments can then be ligated into a vector plasmid (for this experiment 
pHSG398) for size and sequence analysis [1].  
These results can then be complied to construct genetic library, which can be 
used as a reference point for further research into specific genes as well as 
comparisons between different genomes [24].  Similar techniques can be used if a 
recombinant is easily identifiable (colour expression), in this case only clones 
expressing the recombinant would be analysed [22]. 
This experiment has similar methodology to that of Pemberton and colleagues 
(1991), except for this experiment violacein is being extracted from pJP101, and 
inserted into pHSG398.  In this experiment it was expected that the clones that 
expressed violacein, when digestion would give two fragments.  One fragment from 
the digestion would pHSG398, as it has only one BamHI restriction site, and 
another between 8,000 to 14,500 bp. 
4. Methodology 
The methodology focuses on using: 
• Digestion of vector, 
• Ligation of Vector into target plasmid, 
• Transformation and plating, and 
• Cell lysis and electrophoresis. 
4.1. Digestion of vector 
The cosmid pJP101 digested using serially diluted Sau3AI (1:1) for digestion, 
starting with a 60 µL master mixture containing; 40 µL of pJP101, 10 µL buffer, 10 
units of Sau3AI. 30 µL of the master solution was added to a 30 µL solution 
containing; 20 µL of pJP101, 1x buffer, giving dilution factor 0.5.  
This dilution was performed 5 times. Samples where digested at 37
°
C for 15 
minutes, after this time digestion was stopped by incubating at 85
°
C for 15 minutes.  
Each digestion was run on an electrophoresis gel.  Digestion samples which had 
gel bands ≥8 kbp where selected for ligation. 
4.2. Ligation of Vector into target plasmid 
The vector fragment ligation (pHSG398) was digested for 1 hour at 37
°
C in; 10 
units of BamHI, 1x restriction buffer and 10 µL pHSG398.  Samples were heated at 
70
°
C for 10 minutes. Digested pHSG398 and the serial digests of pJP101 where 
ligated in a solution of; 10 µL of each DNA sample, 1x ligation buffer, 1 unit of T4 
ligase.  This solution was left for 16 hours at 16
°
C. 
4.3. Transformation and plating 
For transformation 25 µL of the following; ligation samples, pJP101, pHSG398 
and TE buffer where added to separate 200 µL of JM109 cells, sample where left 
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on ice for 10 minutes, then incubated at 37
°
C for 5 minutes.  Each sample had 500 
µL of LB broth added, after which they were incubated at 37
O
C for 45 minutes.  
The ligation cell cultures where added to agar plates with either 
Ampercillin100µg/mL to check for contamination by pJP101 or Kamermycin100µg/mL to 
screen for recombinants (see table 1 for set up).  Cultures were re-plated every 24 
hours for 3 days.  Positive ligation results were picked for further analysis. 
4.4. Cell lysis and electrophoresis 
Clones that produced a purple pigment where re-suspended in a 200 µL 
solution; 50 mM glucose, 25 mM TrisHCl and 10 mM EDTA. 200 µL of a lyse 
solution containing; 200 mM NaOH and 1% SDS, was then added to the cell 
mixture.  This new solution was left on ice for 5 minutes. The solution was 
centrifuged at 20,000 rpm, the supernatant was transferred to a fresh 1.5 mL tube, 
and pellet was discarded.  
The supernatant was left to incubate at room temperature for 10 minutes. 450 
µL of isopropanol was added to the supernatant, and left at room temperature for 
10 minutes.  This solution was then centrifuged at 20,000 rpm for 10 minutes.  The 
supernatant was discarded and the pellet was rinsed with 70% ethanol centrifuged 
at 20,000 rpm for 5 minutes, supernatant was discarded and pellet was air dried 
and re-suspended in sterile H2O. Isolated plasmids had undigested and samples 
digested with BamHI electrophoresed for analysis. 
5. Results 
After the dilution digests with Sau3AI on pJP101 was performed, the digests where 
ran on a electrophoresis gel to see if there were any digests that produced 
fragments large enough to contain the whole violcein sequence (fragments ≥ 8kb). 
When the serial enzyme dilution digests where examined with gel 
electrophoresis gave four samples containing fragments large enough to contain 
the violacein sequence (≥8 kbp).  Sample pJP101
0.5Sau3AI
 gave a range of bands 
from 8 to 10 kb and another 20 kb.  All other sample from this digest mainly shows 
bands 9 kb or larger (Figure 6).  These samples could then be ligated with 
pHSG398 digested using BamHI. 
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Figure 6. The partial digests of pHSG398 with Sau3AI. The contests of each gel lane are; pHSG398 
digested with BamHI (I), pJP101 digested with 0.500 units of Sau3AI (II), pJP101 digested with 0.250 
units of Sau3AI (III), pJP101 digested with 0.125 units of Sau3AI (IV), pJP101 digested with 0.063 units 
of Sau3AI (V). 
Following the ligation of genetic material into pHSG398 and the uptake 
recombinants by JM109 cells, the clones where plated along with control cultures 
(Table 1).  There was no unexpected growth on the Ampercillin100µg/mL control 
plates.  Clones expressing violacein were found in all Kamermyicin100µg/mL plates 
with 400 µL of culture. Sample pJP101
0.5Sau3AI
 also showed purple colonies when 
plated using 200 µL of culture. 
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Table 1. Results of plating the ligations, the table show contents of plates, antibiotic resistance and 
cfu/mL. When plates where not use, they were marked with 'not applicable' (N/A). 
Sample Volume Colour Plate (cfu/mL) 
Ampicillin100µg/mL 
Plate (cfu/mL) 
Kamermycin100µg/mL 
pJP101 100 µL Purple 
White 
80 
330 
0 
0 
pHSG398 100 µL Purple 
White  
0 
0 
0 
760 
TE buffer  100 µL Purple 
White  
0 
0 
0 
0 
I 100 µL Purple 
White 
N/A 
N/A 
0 
170 
I 200 µL Purple 
White  
N/A 
N/A 
0 
200 
I  400 µL Purple 
White  
N/A 
N/A 
3 
293 
II 100 µL Purple 
White 
N/A 
N/A 
0 
270 
II 200 µL Purple 
White  
N/A 
N/A 
5 
251 
II  400 µL Purple 
White  
N/A 
N/A 
3 
238 
III 100 µL Purple 
White 
N/A 
N/A 
0 
340 
III 200 µL Purple 
White  
N/A 
N/A 
5 
270 
III  400 µL Purple 
White  
N/A 
N/A 
5 
245 
IV 100 µL Purple 
White 
N/A 
N/A 
0 
315 
IV 200 µL Purple 
White  
N/A 
N/A 
0 
335 
IV 400 µL Purple 
White  
N/A 
N/A 
5 
270 
 
Clones expressing violacein were re-plated, re-suspended in culture and lysed 
to extract there genetic material for analysis by electrophoresis.  The lysed clones 
had two samples of each on a electrophoresis gel; undigested and digested.  
All cut ligation samples showed two bands, one the size of pHSG398 and 
another between 9416 and 23130 bp.  Cut ligation samples I and III had the 
smallest inserts from pJP101.  The uncut ligation sample I showed two bands, one 
near 9416 bp and another near 23130 bp, all other uncut samples showed smears, 
blodges and multiple bands (Figure 7). 
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Figure 7. The re-digests of the successful ligations where digested with HindIII, gel contents are; 
Digested pHSG398 (I), cut pJP101
0.5Sau3AI
  (II), uncut pJP101
0.5Sau3AI
  (III), cut pJP101
0.25Sau3AI
 (IV), uncut 
pJP101
0.25Sau3AI
 (V), cut pJP101
0.125Sau3AI
  (VI), uncut pJP101
0.125Sau3AI
 (VII), measurements to calculate 
molecular weights where taken from the checkered line. Molecular weights where compared to those 
produced by λ/ HindIII marker. Regions of interests (bands other than pHSG398) where outlined. 
6. Discussion 
The results from the partial digestion showed that pJP101 had been fragmented.  
In each gel the largest band (~20 kb) this band was uncut pJP101, which has a 
molecular weight of 19 kb [22].  Every digest sample gave bands that where large 
enough to contain the violacein gene, these bands where ≥9 kb. Sample 
pJP101
0.5Sau3AI
 also gave bands between 8 kb and 9 kb.  
6.1. Digestion  
The results of the serial digestion of pJP101 (Figure 6) had given fragments 
that could possibly contain violacein [11].  These fragments produced where 
smaller than the one originally inserted into pJP101, which was 14 kb, meaning we 
had not simply re-extracted that sequence [22]. 
The data from the plating analysis (Table 1) shows that even though all the 
pJP101 had contains the violacein sequence, not all colonies would be purple.  
This result had also been show in other research [25].  The low rates of expression 
of the violacein where mostly due to insertions containing only some, or even none 
of the biosynthetic pathway.  What was highlighted was that the rates of production 
may be reduced as violacein production is low and unstable in E.coli [26].  This 
indicates that identifiable clones would occur in small numbers, as not all clones 
containing the violacein genes would give a positive result.  Each of the ligation 
samples showed clones expressing the violacein gene in small concentrations 
(between 3-5 cfu/mL). 
The re-digested samples (Figure 7) gave two bands, the smaller of the two 
bands was 2.2 kbp, this band was the cut vector, as it was the same size and the 
pHSG398 band digested with BamHI.  As an outcome, the smallest functional 
violacein fragment obtained from re-digestion was 9.5 kbp. This fragment is larger 
than the complete violacein sequence [11]. 
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6.2. Stability 
This study has shown that it is possible to further isolate the violacein 
sequence using Sau3AI, and express it in a clone organism using similar 
techniques used to create a genome library.  A cautionary note is made, that is 
there where technical problems with this experiment, mainly centered with the 
production rates and stability of violacein. 
Both wild types and clones of violacein have low, unstable production rates.  
These problems occur because non-violacein producing variants occur 
spontaneously.  This usually happens at a higher frequency when hyper-producing 
violacein colonies are replanted [26]. 
Recent studies have showed it is possible to produce high levels of stable 
violacein in E.coli.   This may be done by combining the genetic material from 
stable lines of E.coli that produce low levels of violacein with strains that over 
produce violacein, but are unstable.  The resulting strains of E.coli could produce 
high levels of violacein stably for multiple generations [25].  
6.3. DNA Logic gates 
The connection to DNA biological logic gate is made via an experiment that 
had the aim of trying and extracts the smallest possible fragment from Plasmid 
JP101 created by Pemeberton and colleagues (1991) which contained the 
violacein genes [22]. 
Both the instability and stability states could be used as 'switches' as part of a 
DNA (biorheological) logic gate block(s) as suggested in Figure 3.  With an 
increase production rates this may be an enabler to assist organ additive 
fabrication or biofabrication of DNA (biorheological) logic gates. Organ additive 
fabrication or biofabrication has provided the opportunity for rheology to play a key 
role in developing polymer scaffolds to light medical biorheological devices.  
This may additionally suggest biorheology logic gates reprogramming 
(encoding-decoding) vaccine pathways.  Such an approach may enable the 
development of biorheological creams, gels, glues, slims or foams that could be 
biofabricated as programmed logic controllers through to artificial wisdom intelligent 
based systems to overcome various related patient medical conditions [27]. 
7. Conclusions 
The hypothesis has been validated as plausible (extraction of the violacein 
sequence from pJP101 for expression and analysis in pHSG398 determine the 
smallest DNA fragment responsible for purple pigmentation).  It may also be 
possible to regulate and increase the production of violacein, via the use of quorum 
sensing.  
Quorum sensing is where small diffusible signaling molecules are used as 
activators and it is used in both intra- and extra cellular communication [28].  It has 
been suggested that introduction of certain quorum sensing particles can increase 
the production rates of violacein [29]. 
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This experiment showed it is possible to: 
• Further isolate the genes responsible for producing violacein from pJP101, 
and has hinted that it may be possible to increase production rates via 
genetic manipulation and introduction of quorum sensing particles, and 
• Use the instability and stability states as 'switches' as part of a DNA 
(biorheological) logic gate block(s) for gene reprogramming.  Logic gates 
(input to output logic operations) are a growing research field to enable 
biological devices using scalable DNA combinational logic gates.  These 
devices tend to have biochemistry drivers to distinguish devices within a 
circuit [30].   
8. Future research 
Future research is proposed in using this papers conclusion.  The focus is on 
Organ additive fabrication or biofabrication.  This provides the opportunity for a 
hybrid biology and rheology to play a key role in developing polymer scaffolds to 
light medical biorheological devices.  
The developed biorheological material and devices might not only be used in 
biofabrication but might take the next step as a countermeasure or intervention.  As 
an example, by developing biorheological creams, gels, glues, slims or foams that 
could be biofabricated as programmed logic controllers through to artificial wisdom 
intelligent based systems to overcome various related patient medical conditions. 
It may also be possible to further control the expression of engineer microbes, 
using DNA logic gates which are activated by qurom sensing particles and/or 
proteins, to express antimicrobials as a means of treating resistant microbes [4], 
and as a means to have greater control over expression in a constantly fluctuating 
cellular environment [31]. 
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